Sir,
Talwar and colleagues raise very valid points, and we agree with all of them. The need for worldwide trials of antibiotics is obvious, as we suggested in our manuscript. Adjustment for local epidemiologic and demographic conditions will be important for making informed and useful recommendations. A recent visit we made to the very impressive home institution of the authors confirms that they will be well positioned to contribute to future studies of this type.